Literature DB >> 7638206

Physical mapping of the minimal region of loss in 5q- chromosome.

J Fairman1, I Chumakov, A C Chinault, P C Nowell, L Nagarajan.   

Abstract

Acquired interstitial loss of all or part of the long arm of human chromosome 5 (5q-) is an anomaly that is seen frequently in patients with preleukemic myelodysplasia and acute myelogenous leukemia. Loss of a critical region of overlap at band 5q31.1 in all of these cases, with various cytogenetic breaks, signifies the existence of a key negative regulator of leukemogenesis. Previous studies have defined the proximal and distal ends of the critical region to reside between the genes for IL9 and EGR1, respectively. In this report, we describe a yeast artificial chromosome contig spanning this myeloid tumor suppressor locus. The combined order of the polymorphic loci is centromere-IL9-(D5S525-D5S558-D5S89-D5S526 -D5S393)-D5S399-D5S396-D5S414-EGR1 and telomere. The physical distance between the IL9 and EGR1 genes is estimated to be < 2.4 Mb. Here we report the utility of these polymorphic loci by detecting a submicroscopic deletion of 5q31; an acute myelogenous leukemia patient with a three-way translocation, t(5;18;17)(q31;p11;q11), as the sole anomaly revealed allele loss of the D5S399 and D5S396 loci.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7638206      PMCID: PMC41348          DOI: 10.1073/pnas.92.16.7406

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  25 in total

1.  A radiation hybrid map of 18 growth factor, growth factor receptor, hormone receptor, or neurotransmitter receptor genes on the distal region of the long arm of chromosome 5.

Authors:  J A Warrington; S K Bailey; E Armstrong; O Aprelikova; K Alitalo; G M Dolganov; A S Wilcox; J M Sikela; S F Wolfe; M Lovett
Journal:  Genomics       Date:  1992-07       Impact factor: 5.736

2.  A second-generation linkage map of the human genome.

Authors:  J Weissenbach; G Gyapay; C Dib; A Vignal; J Morissette; P Millasseau; G Vaysseix; M Lathrop
Journal:  Nature       Date:  1992-10-29       Impact factor: 49.962

3.  Rapid identification of yeast artificial chromosome clones by matrix pooling and crude lysate PCR.

Authors:  T J Kwiatkowski; H Y Zoghbi; S A Ledbetter; K A Ellison; A C Chinault
Journal:  Nucleic Acids Res       Date:  1990-12-11       Impact factor: 16.971

4.  Deletion of 5q by t(5;17) in therapy-related myelodysplastic syndrome.

Authors:  E A Vandenberghe; C Mecucci; A Delannoy; H Van den Berghe
Journal:  Cancer Genet Cytogenet       Date:  1990-08-01

Review 5.  The 5q- abnormality.

Authors:  S D Nimer; D W Golde
Journal:  Blood       Date:  1987-12       Impact factor: 22.113

6.  Molecular anatomy of a 5q interstitial deletion.

Authors:  L Nagarajan; B Lange; L Cannizzaro; J Finan; P C Nowell; K Huebner
Journal:  Blood       Date:  1990-01-01       Impact factor: 22.113

7.  Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus.

Authors:  D Viskochil; A M Buchberg; G Xu; R M Cawthon; J Stevens; R K Wolff; M Culver; J C Carey; N G Copeland; N A Jenkins
Journal:  Cell       Date:  1990-07-13       Impact factor: 41.582

Review 8.  Cytogenetics.

Authors:  C Mecucci; H Van den Berghe
Journal:  Hematol Oncol Clin North Am       Date:  1992-06       Impact factor: 3.722

9.  Multiplex PCR of three dinucleotide repeats in the Prader-Willi/Angelman critical region (15q11-q13): molecular diagnosis and mechanism of uniparental disomy.

Authors:  A Mutirangura; F Greenberg; M G Butler; S Malcolm; R D Nicholls; A Chakravarti; D H Ledbetter
Journal:  Hum Mol Genet       Date:  1993-02       Impact factor: 6.150

10.  Clinical and cytogenetic correlations in 63 patients with therapy-related myelodysplastic syndromes and acute nonlymphocytic leukemia: further evidence for characteristic abnormalities of chromosomes no. 5 and 7.

Authors:  M M Le Beau; K S Albain; R A Larson; J W Vardiman; E M Davis; R R Blough; H M Golomb; J D Rowley
Journal:  J Clin Oncol       Date:  1986-03       Impact factor: 44.544

View more
  15 in total

Review 1.  Molecular dissection of the 5q deletion in myelodysplastic syndrome.

Authors:  Benjamin L Ebert
Journal:  Semin Oncol       Date:  2011-10       Impact factor: 4.929

2.  Molecular delineation of the smallest commonly deleted region of chromosome 5 in malignant myeloid diseases to 1-1.5 Mb and preparation of a PAC-based physical map.

Authors:  N Zhao; A Stoffel; P W Wang; J D Eisenbart; R Espinosa; R A Larson; M M Le Beau
Journal:  Proc Natl Acad Sci U S A       Date:  1997-06-24       Impact factor: 11.205

Review 3.  Myelodysplastic syndromes.

Authors:  Olatoyosi Odenike; John Anastasi; Michelle M Le Beau
Journal:  Clin Lab Med       Date:  2011-10-10       Impact factor: 1.935

4.  AF5q31, a newly identified AF4-related gene, is fused to MLL in infant acute lymphoblastic leukemia with ins(5;11)(q31;q13q23).

Authors:  T Taki; H Kano; M Taniwaki; M Sako; M Yanagisawa; Y Hayashi
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-07       Impact factor: 11.205

5.  Evolutionary conservation of zebrafish linkage group 14 with frequently deleted regions of human chromosome 5 in myeloid malignancies.

Authors:  Ting Xi Liu; Yi Zhou; John P Kanki; Min Deng; Jennifer Rhodes; Hong Wei Yang; Xiao Ming Sheng; Leonard I Zon; A Thomas Look
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-30       Impact factor: 11.205

Review 6.  DNA copy number losses in human neoplasms.

Authors:  S Knuutila; Y Aalto; K Autio; A M Björkqvist; W El-Rifai; S Hemmer; T Huhta; E Kettunen; S Kiuru-Kuhlefelt; M L Larramendy; T Lushnikova; O Monni; H Pere; J Tapper; M Tarkkanen; A Varis; V M Wasenius; M Wolf; Y Zhu
Journal:  Am J Pathol       Date:  1999-09       Impact factor: 4.307

Review 7.  Cytogenetic and genetic pathways in therapy-related acute myeloid leukemia.

Authors:  Zhijian Qian; John M Joslin; Thelma R Tennant; Shalini C Reshmi; David J Young; Angela Stoddart; Richard A Larson; Michelle M Le Beau
Journal:  Chem Biol Interact       Date:  2009-12-01       Impact factor: 5.192

8.  Progressive chromatin repression and promoter methylation of CTNNA1 associated with advanced myeloid malignancies.

Authors:  Ying Ye; Michael A McDevitt; Mingzhou Guo; Wei Zhang; Oliver Galm; Steven D Gore; Judith E Karp; Jaroslaw P Maciejewski; Jeanne Kowalski; Hua-Ling Tsai; Lukasz P Gondek; Hsing-Chen Tsai; Xiaofei Wang; Craig Hooker; B Douglas Smith; Hetty E Carraway; James G Herman
Journal:  Cancer Res       Date:  2009-10-13       Impact factor: 12.701

9.  Evidence of EGR1 as a differentially expressed gene among proliferative skin diseases.

Authors:  Min Fang; Sue Ann Wee; Karyn Ronski; Hongran Fan; Shiying Tao; Qun Lin
Journal:  Genomic Med       Date:  2007-07-25

10.  Genetic pathways leading to therapy-related myeloid neoplasms.

Authors:  Angela Stoddart; Megan E McNerney; Elizabeth Bartom; Rachel Bergerson; David J Young; Zhijian Qian; Jianghong Wang; Anthony A Fernald; Elizabeth M Davis; Richard A Larson; Kevin P White; Michelle M Le Beau
Journal:  Mediterr J Hematol Infect Dis       Date:  2011-05-16       Impact factor: 2.576

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.